Pay-to-delay Deals keep Consumer Prices artificially high to protect Drug Patent-Holders’ Profits

” … When a company’s patent on a brand-name drug expires, other companies are free to make generic versions of the same drug… Often times, there are legal disputes between brand-name drug manufacturers and generic-drug companies. It’s increasingly common for this litigation to end with out-of-court settlements in which patentholders pay potential competitors to delay the introduction of generics.
That’s pay-to-delay… ”

Read PD Editorial: Pay-to-delay deals costly for consumers.

Read How ‘Pay for Delay’ Keeps Us Paying More for Prescription Drugs.